Document Detail


Blockade of PKCdelta proteolytic activation by loss of function mutants rescues mesencephalic dopaminergic neurons from methylcyclopentadienyl manganese tricarbonyl (MMT)-induced apoptotic cell death.
MedLine Citation:
PMID:  15681813     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The use of methylcyclopentadienyl manganese tricarbonyl (MMT) as a gasoline additive has raised health concerns and increased interest in understanding the neurotoxic effects of manganese. Chronic exposure to inorganic manganese causes Manganism, a neurological disorder somewhat similar to Parkinson's disease. However, the cellular mechanism by which MMT, an organic manganese compound, induces neurotoxicity in dopaminergic neuronal cells remains unclear. Therefore, we systematically investigated apoptotic cell-signaling events following exposure to 3-200 microM MMT in mesencephalic dopaminergic neuronal (N27) cells. MMT treatment resulted in a time- and dose-dependent increase in reactive oxygen species generation and cell death in N27 cells. The cell death was preceded by sequential activation of mitochondrial-dependent proapoptotic events including cytochrome c release, caspase-3 activation, and DNA fragmentation, indicating that the mitochondrial-dependent apoptotic cascade primarily triggers MMT-induced apoptotic cell death. Importantly, MMT induced proteolytic cleavage of protein kinase Cdelta (PKCdelta), resulting in persistently increased kinase activity. The proteolytic activation of PKCdelta was suppressed by treatment with 100 microM Z-VAD-FMK and 100 microM Z-DEVD-FMK, suggesting that caspase-3 mediates the proteolytic activation of PKCdelta. Pretreatment with 100 microM Z-DEVD-FMK and 5 microM rottlerin (a PKCdelta inhibitor) also significantly attenuated MMT-induced DNA fragmentation. Furthermore, overexpression of either the kinase inactive dominant negative PKCdelta(K376R) mutant or the caspase cleavage resistant PKCdelta(D327A) mutant rescued N27 cells from MMT-induced DNA fragmentation. Collectively, these results demonstrate that the mitochondrial-dependent apoptotic cascade mediates apoptosis via proteolytic activation of PKCdelta in MMT-induced dopaminergic degeneration and suggest that PKCdelta may serve as an attractive therapeutic target in Parkinson-related neurological diseases.
Authors:
V Anantharam; M Kitazawa; C Latchoumycandane; A Kanthasamy; A G Kanthasamy
Related Documents :
11857353 - Lysosomal proteases as potential targets for the induction of apoptotic cell death in h...
10079203 - Liver poly(adp-ribose)polymerase is resistant to cleavage by caspases.
12736263 - Elucidation of molecular events leading to neutrophil apoptosis following phagocytosis:...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  Annals of the New York Academy of Sciences     Volume:  1035     ISSN:  0077-8923     ISO Abbreviation:  Ann. N. Y. Acad. Sci.     Publication Date:  2004 Dec 
Date Detail:
Created Date:  2005-01-31     Completed Date:  2006-07-13     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  7506858     Medline TA:  Ann N Y Acad Sci     Country:  United States    
Other Details:
Languages:  eng     Pagination:  271-89     Citation Subset:  IM    
Affiliation:
Parkinson's Disorder Research Laboratory, Department of Biomedical Sciences, Iowa State University, Ames, IA 50011, USA. akanthas@iastate.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Animals, Newborn
Apoptosis / drug effects*
Blotting, Western / methods
Caspase 3
Caspases / metabolism
Cell Count / methods
DNA Fragmentation / drug effects
Dopamine / metabolism*
Dose-Response Relationship, Drug
Enzyme Activation / drug effects
Enzyme Inhibitors / pharmacology
Enzyme-Linked Immunosorbent Assay / methods
Flow Cytometry / methods
Immunoprecipitation / methods
Mesencephalon / cytology*
Mutation / physiology
Neurons / drug effects*,  metabolism
Organometallic Compounds / pharmacology*
Protein Kinase C-delta / metabolism*
Rats
Reactive Oxygen Species / metabolism
Systole
Transfection / methods
Grant Support
ID/Acronym/Agency:
ES10586/ES/NIEHS NIH HHS; NS38644/NS/NINDS NIH HHS; NS45133/NS/NINDS NIH HHS
Chemical
Reg. No./Substance:
0/Enzyme Inhibitors; 0/Organometallic Compounds; 0/Reactive Oxygen Species; 12108-13-3/2-methylcyclopentadienyl manganese tricarbonyl; EC 2.7.11.13/Protein Kinase C-delta; EC 3.4.22.-/Casp3 protein, rat; EC 3.4.22.-/Caspase 3; EC 3.4.22.-/Caspases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The role of alpha-synuclein in both neuroprotection and neurodegeneration.
Next Document:  New therapeutic strategies and drug candidates for neurodegenerative diseases: p53 and TNF-alpha inh...